INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
0440.054.752 · rovalta.com · 27/09/2026
ACTIVE
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
Financial year 2025 · Closed on 31/12/2025
Net result595,6 k €+71,9 %over 1 year
Gross margin1,4 M €+29,1 %over 1 year
Equity8,7 M €+7,0 %over 1 year
Workforce2,7 ETP-10,0 %over 1 year
Overview
Identity
Source · BCE/KBOINCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT is a Public limited company incorporated in 1990. Its main activity is: Other professional, scientific and technical activities. Its registered office is in Gent. It employs on average 2,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0440.054.752
- Incorporation
- 23/01/1990
- Legal form
- Public limited company
- Registered office
- Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map - Contributed capital
- 1 638 414,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,7 ETP
Activities (NACE)
Joint committees (3)
- 100
- 200
- 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,4 M € | +29.1% | 1,1 M € | -19.0% | 1,4 M € | -0.6% | 1,4 M € | +22.2% | 1,1 M € |
| EBITDA | 1,2 M € | +37.6% | 866 k € | -25.2% | 1,2 M € | +5.0% | 1,1 M € | +26.9% | 869,2 k € |
| Operating result | 804,2 k € | +73.8% | 462,7 k € | -37.8% | 743,9 k € | +7.4% | 692,6 k € | +48.5% | 466,3 k € |
| Net result | 595,6 k € | +71.9% | 346,5 k € | -31.9% | 508,8 k € | +1.4% | 502 k € | +62.6% | 308,7 k € |
| Balance sheet | |||||||||
| Equity | 8,7 M € | +7.0% | 8,2 M € | +4.2% | 7,8 M € | +6.6% | 7,4 M € | +7.3% | 6,9 M € |
| Total assets | 10,5 M € | +4.0% | 10,1 M € | +2.1% | 9,9 M € | +2.6% | 9,7 M € | +6.6% | 9,1 M € |
| Cash | 3,9 M € | +5.7% | 3,7 M € | +14.0% | 3,2 M € | +6.7% | 3 M € | +29.4% | 2,3 M € |
| Debts | 1,6 M € | -7.5% | 1,7 M € | -8.2% | 1,9 M € | -8.3% | 2 M € | +4.8% | 1,9 M € |
| Other | |||||||||
| Workforce | 2,7 ETP | -10.0% | 3,0 ETP | +15.4% | 2,6 ETP | -3.7% | 2,7 ETP | -10.0% | 3,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/202512 active · 143 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Sas van Rouveroij van Nieuwaal | Director | 30/05/2024 → 02/06/2026 | |
Sofie BRACKE | Director | 19/12/2023 → 02/06/2026 | 00 |
Didier REYNAERTS | Vice-chairman of the board of directors | 17/05/2022 → 02/06/2026 | 0 |
Eric BOODTS | Director | 17/05/2022 → 02/06/2026 | |
Marnix BOTTE | Managing director | 11/04/2022 → 02/06/2026 | 00 |
André FRANCQ | Director | 14/09/2020 → 02/06/2026 | 00 |
Carl DE MARE | Director | 14/09/2020 → 02/06/2026 | |
Koen STEPMAN | Director | 14/09/2020 → 02/06/2026 | |
Koenraad GOETHALS | Director | 14/09/2020 → 02/06/2026 | 000 |
Mieke HULLEBROECK | Director | 14/09/2020 → 02/06/2026 | |
| Director | 14/09/2020 → 02/06/2026 | 00 | |
Yannick DE CLERCQ | Director | 14/09/2020 → 02/06/2026 | 0 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Sofie BRACKE | Director | 19/12/2023 → 19/05/2026 | 00 |
| Director | 14/09/2022 → 19/05/2026 | 00 | |
Didier REYNAERTS | Vice-chairman of the board of directors | 17/05/2022 → 19/05/2026 | 0 |
Eric BOODTS | Director | 17/05/2022 → 19/05/2026 |
Other companies at this address
Technologiepark-Zwijnaarde 82 9052 Gent| Company | CBE no. |
|---|---|
Amalus Therapeutics● Bankrupt | 0803.929.268 |
APCOR R&M● Active | 0600.952.909 |
Ardoyen● Active | 0875.102.821 |
AVROXA● Active | 0687.774.936 |
Benebiose● Active | 0784.521.548 |
BioNeering● Active | 0807.194.309 |
CONTREL EUROPE● Active | 0426.204.637 |
CRODEON TECHNOLOGIES● Active | 0642.754.761 |
Cryptobiotix● Active | 0762.565.104 |
Gulliver Biomed● Active | 0692.527.837 |
ImplicitMeasures.com● Bankrupt | 0657.989.701 |
Inbiose● Active | 0534.887.593 |
INNOVATIVE PHARMACEUTICS● Active | 0883.574.582 |
Inspect● Active | 0645.950.417 |
INVIBES ADVERTISING● Active | 0836.533.938 |
KYTOS● Active | 0768.755.286 |
Lares Solutions● Active | 1015.346.906 |
| 0755.350.975 | |
| 0742.910.132 | |
| 0667.765.816 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 05/09/2025 | 24/07/2024 | 29/08/2023 | 09/06/2022 | 31/07/2021 |
| General meeting | 02/06/2026 | 20/05/2025 | 30/05/2024 | 16/05/2023 | 17/05/2022 | 18/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 02/06/2026 | 31/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 20/05/2025 | 05/09/2025 | Dutch | |
| Abridged model | 31/12/2023 | 30/05/2024 | 24/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 16/05/2023 | 29/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 17/05/2022 | 09/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 18/05/2021 | 31/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 14/09/2020 | 03/05/2021 | Dutch | |
| Abridged model | 31/12/2018 | 21/05/2019 | 31/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 15/05/2018 | 19/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 16/05/2017 | 18/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 17/05/2016 | 14/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 19/05/2015 | 24/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 20/05/2014 | 31/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 21/05/2013 | 30/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 15/05/2012 | 30/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 17/05/2011 | 25/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 18/05/2010 | 30/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 19/05/2009 | 22/07/2009 | Dutch | |
| Abridged model | 31/12/2007 | 20/05/2008 | 23/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 15/05/2007 | 06/07/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202512 active · 143 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Sas van Rouveroij van Nieuwaal | Director | 30/05/2024 → 02/06/2026 | |
Sofie BRACKE | Director | 19/12/2023 → 02/06/2026 | 00 |
Didier REYNAERTS | Vice-chairman of the board of directors | 17/05/2022 → 02/06/2026 | 0 |
Eric BOODTS | Director | 17/05/2022 → 02/06/2026 | |
Marnix BOTTE | Managing director | 11/04/2022 → 02/06/2026 | 00 |
André FRANCQ | Director | 14/09/2020 → 02/06/2026 | 00 |
Carl DE MARE | Director | 14/09/2020 → 02/06/2026 | |
Koen STEPMAN | Director | 14/09/2020 → 02/06/2026 | |
Koenraad GOETHALS | Director | 14/09/2020 → 02/06/2026 | 000 |
Mieke HULLEBROECK | Director | 14/09/2020 → 02/06/2026 | |
| Director | 14/09/2020 → 02/06/2026 | 00 | |
Yannick DE CLERCQ | Director | 14/09/2020 → 02/06/2026 | 0 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Sofie BRACKE | Director | 19/12/2023 → 19/05/2026 | 00 |
| Director | 14/09/2022 → 19/05/2026 | 00 | |
Didier REYNAERTS | Vice-chairman of the board of directors | 17/05/2022 → 19/05/2026 | 0 |
Eric BOODTS | Director | 17/05/2022 → 19/05/2026 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates05/07/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DOEL - ONTSLAGEN - BENOEMINGEN - BENAMING
- Mandates30/03/2023ONTSLAGEN - BENOEMINGEN
- Mandates03/01/2020MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates23/03/2015ONTSLAGEN - BENOEMINGEN
- Mandates03/04/2012ONTSLAGEN - BENOEMINGEN
- Capital / shares31/05/2006KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates16/11/2005ONTSLAGEN - BENOEMINGEN
- Mandates16/11/2005ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025595,6 k €↑
- 2024Annual accounts 2024346,5 k €↓
- 2024Name changeINCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
- 2023Annual accounts 2023508,8 k €↑
- 2022Annual accounts 2022502 k €↑
- 2022Name changeIIC UGENT
- 2021Annual accounts 2021308,7 k €↓
- 2020Annual accounts 2020386,1 k €↑
- 2019Annual accounts 2019333,9 k €↑
- 2018Annual accounts 2018323,4 k €↑
- 2017Annual accounts 2017312,4 k €↑
- 2016Annual accounts 2016266,1 k €↑
- 2015Annual accounts 2015159,2 k €↓
- 2014Annual accounts 2014539 k €↑
- 2013Annual accounts 2013215,1 k €↓
- 2012Annual accounts 2012254,2 k €↑
- 2011Annual accounts 2011243,7 k €↑
- 2010Annual accounts 2010221 k €↑
- 2009Annual accounts 2009202,3 k €↑
- 2008Annual accounts 2008161,6 k €↑
- 2007Annual accounts 2007132,8 k €↑
- 2006Annual accounts 200682,3 k €
- 23/01/1990IncorporationPublic limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Technologiepark-Zwijnaarde 82, 9052 ZwijnaardeCurrent | accounts 2023 → 2025 · CBE, tracked since 27/09/2026 | Accounts 2025 · 2026-00465138 |
| Technologiepark Zwijnaarde 3, 9052 Zwijnaarde | accounts 2022 | Accounts 2022 · 2023-00390732 |
| Technologiepark 3, 9052 Zwijnaarde | accounts 2021 | Accounts 2021 · 2022-20061604 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEITCurrent | accounts 2024 → 2025 · CBE, tracked since 27/09/2026 | Accounts 2025 · 2026-00465138 |
| IIC UGENT | accounts 2022 → 2023 | Accounts 2023 · 2024-00280140 |
| IICUGENT | accounts 2021 | Accounts 2021 · 2022-20061604 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.